StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) income statement

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3036% below fair value
$3.11−0.07 (-2.20%)

Close on Nov 19, 2026Market cap $453.83MP/E –Yield –

MiMedx Group, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
77.3%
Operating margin
-8.3%
Net margin
-6.3%
Return on equity, FY2025
21.6%

Financial strength

Current ratio
4.35
Debt to equity
0.00
Debt to assets
0.0%
Cash to current liabilities
280.7%

Valuation

P/E ratio
–
Price to sales
1.49
Price to book
2.15
Dividend yield
–

See a number that looks wrong?